199 related articles for article (PubMed ID: 9458681)
1. HIV-associated nephropathy.
Winston J; Klotman PE
Mt Sinai J Med; 1998 Jan; 65(1):27-32. PubMed ID: 9458681
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated nephropathy: case study and review of the literature.
Ross MJ; Klotman PE; Winston JA
AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated nephropathy and end-stage renal disease in children in the United States.
Ahuja TS; Abbott KC; Pack L; Kuo YF
Pediatr Nephrol; 2004 Jul; 19(7):808-11. PubMed ID: 15141343
[TBL] [Abstract][Full Text] [Related]
5. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy.
Winston JA; Burns GC; Klotman PE
Semin Nephrol; 1998 Jul; 18(4):373-7. PubMed ID: 9692350
[TBL] [Abstract][Full Text] [Related]
6. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.
Bruggeman LA; Dikman S; Meng C; Quaggin SE; Coffman TM; Klotman PE
J Clin Invest; 1997 Jul; 100(1):84-92. PubMed ID: 9202060
[TBL] [Abstract][Full Text] [Related]
7. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment.
Herman ES; Klotman PE
Semin Nephrol; 2003 Mar; 23(2):200-8. PubMed ID: 12704580
[TBL] [Abstract][Full Text] [Related]
10. Is the prevalence of HIV-associated nephropathy decreasing?
Ahuja TS; Borucki M; Funtanilla M; Shahinian V; Hollander M; Rajaraman S
Am J Nephrol; 1999; 19(6):655-9. PubMed ID: 10592359
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated nephropathy: an urban epidemic.
Monahan M; Tanji N; Klotman PE
Semin Nephrol; 2001 Jul; 21(4):394-402. PubMed ID: 11455528
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa.
Han TM; Naicker S; Ramdial PK; Assounga AG
Kidney Int; 2006 Jun; 69(12):2243-50. PubMed ID: 16672914
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years' experience.
Ray PE; Rakusan T; Loechelt BJ; Selby DM; Liu XH; Chandra RS
Semin Nephrol; 1998 Jul; 18(4):396-405. PubMed ID: 9692352
[TBL] [Abstract][Full Text] [Related]
14. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.
Sola-Del Valle DA; Mohan S; Cheng JT; Paragas NA; Sise ME; D'Agati VD; Barasch J
Nephrol Dial Transplant; 2011 Jul; 26(7):2387-90. PubMed ID: 21555394
[TBL] [Abstract][Full Text] [Related]
15. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?
Ahuja TS; Collinge N; Grady J; Khan S
Am J Kidney Dis; 2003 May; 41(5):1060-4. PubMed ID: 12722041
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
17. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
18. HIV-Associated Nephropathy among Children with Renal Disease in Port Harcourt, Nigeria.
Uchenwa TA; Anochie IC
West Afr J Med; 2021 Apr; 38(4):307-312. PubMed ID: 33900708
[TBL] [Abstract][Full Text] [Related]
19. A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy.
Ray PE; Liu XH; Robinson LR; Reid W; Xu L; Owens JW; Jones OD; Denaro F; Davis HG; Bryant JL
Kidney Int; 2003 Jun; 63(6):2242-53. PubMed ID: 12753314
[TBL] [Abstract][Full Text] [Related]
20. Predictors of renal outcome in HIV-associated nephropathy.
Post FA; Campbell LJ; Hamzah L; Collins L; Jones R; Siwani R; Johnson L; Fisher M; Holt SG; Bhagani S; Frankel AH; Wilkins E; Ainsworth JG; Larbalestier N; Macallan DC; Banerjee D; Baily G; Thuraisingham RC; Donohoe P; Hendry BM; Hilton RM; Edwards SG; Hangartner R; Howie AJ; Connolly JO; Easterbrook PJ
Clin Infect Dis; 2008 Apr; 46(8):1282-9. PubMed ID: 18444868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
